We would love to hear your thoughts about our site and services, please take our survey here.
From another bulletin board:
"In order to keep the Licenses and keep the projects, it must be a going concern sale. In case of Administration, contracts gets Breached, licenses and Vermelho will be lost. Hence, shareholders might be happy with 1p and Creditors take a haircut on the debt. Suppliers will get something if the project is restarted.Nickel price heading North with the Russian Ban."
I doubt they will let it go into administration as that would mean breach of the licences, could see a low ball takeover as a going concern? At a market cap of £1m, this could be a fair punt to take for a few grand.
DYOR
1p is underwritten by the funds expected today with nothing else priced in, so 2p not out of question once we receive the RNS confirming receipt of funds. Could do 300% today if that RNS is printed today IMO.
Well done all. DYOR
Looks like the bottom has been hit and the SP could bounce higher from here. he chairman bought 2m shares at 6.10p just 3 months ago.
"London, UK, 27 November 2023: Shield Therapeutics plc (LSE:STX), a commercial stage pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol), confirms that Mr Hans Peter Hasler, Chairman, acquired 2,000,000 Ordinary Shares in the Company on 21 November 2023 at a price of 6.1p per share. Mr Hasler now holds a beneficial interest in 5,500,000 Ordinary Shares."
DYOR
Any hint of resolution of the dispute with Stalicla and receipt of monies and this share would go up by several 100% in a flash.
I am quietly confident that the dispute will be resolved -looking for 4p to 5p per share at least. Could even go to 10p IMO.
DYOR
Freefloat about 25m shares: Look at the share register, the CEO owns 45% and ii's own 25% so I cannot see a low ball fundraise, if anything it should be at a premium following all the recent news: https://ir.sondrel.com/investors/shareholder-information
More news: https://www.thisismoney.co.uk/money/markets/article-13062751/Tech-minnow-Sondrel-doubles-value-reports-played-key-Elon-Musks-Neuralink-brain-chip.html
Even if SND cannot reveal the identity of its customers, there is nothing stopping the customers from revealing their links with SND!
Let's see if this goes back to 20p as it did yesterday.
DYOR
Let's see if Elon Musk deepens his ties with Sondrel following this announcement: https://www.proactiveinvestors.co.uk/companies/news/1040520/sondrel-skyrockets-140-on-elon-musk-neuralink-rumours-1040520.html
Sondrel's customer base also includes TESLA and Elon Musk loves technology and the future- any link with him on the share register and the SP could go bonkers here. He could also finance the ongoing operations and meet short term capital requirements.
11p is a good base.
DYOR
Vedanta is huge https://www.cairnindia.com/Pages/Home.aspx
Let’s see if we get to 0.50p once the RNS lands
Dyor
Please stop ramping SND here, REDX has solid news behind it, Seeing SND spike up over 220%, hope people do not get burnt there, REDX is at the same level as yesterday's opening, free float very tiny, less than 60m shares available in the market.
DYOR
MM's collecting shares. REDX should list in the US, its market cap would be 10 times what it is now. https://www.fiercebiotech.com/biotech/jazz-jumps-kras-g12d-space-10m-upfront-deal-regular-partner-redx
DYOR, IMHO
A few sellers exiting, they will buy back much higher IMO.
40p should be hit once this gets going- we saw how quick it went up yesterday-sometimes it takes a few days for the news to be digested.
DYOR
News https://www.pharmaceutical-technology.com/news/jazz-redx-kras-inhibitor/